RecruitingNCT01277419

German Spondyloarthritis Inception Cohort

Sponsor

Charite University, Berlin, Germany

Enrollment

1,000 participants

Start Date

Jul 1, 2000

Study Type

OBSERVATIONAL

Conditions

Ulcerative Colitis (UC)Crohn Disease (CD)Non-radiographic Axial Spondyloarthritis (Nr-axSpA)Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)Axial Psoriatic Arthritis (axPsA)Acute Anterior Uveitis (AAU)

Summary

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

Eligibility

Inclusion Criteria4

Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis.
Patients with definite diagnosis of Crohn's disease.
Patients with definite diagnosis of acute anterior uveitis.
Patients with definite diagnosis of psoriatic arthritis with axial involvement.